Startups
Edit
The Chiesi Group
http://www.chiesigroup.com/Last activity: 17.12.2025
Active - Reference to Chiesi Group
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 25, 2016 | Chiesi Farmaceutici Buys Atopix Therapeutics, for €75M | Chiesi Farmaceutici Spa, a Parma, Italy-based research-focused healthcare group, has signed a definitive agreement for the acquisition of Atopix Therapeutics Limited, an Oxford, UK-based clinical stage biotechnology company developing novel... |
| Nov 21, 2016 | Chiesi Group acquires Atopix | Chiesi Enhances Asthma Portfolio with Acquisition of Atopix Therapeutics |
| Sep 2, 2014 | Chiesi Group Creates Corporate Venture Capital Fund | The Chiesi Group, a Parma, Italy-based research-focused international group which researches, develops and commercializes pharmaceutical solutions in the respiratory therapeutics and specialist medicine areas, has created its corporate vent... |
| Aug 26, 2013 | Chiesi Farmaceutici Acquires Zymenex | Chiesi Farmaceutici SpA, a Parma, Italy-based pharma group, acquired Zymenex Holding A/S, a Danish biopharmaceutical company. The amount of the transaction, conducted by Chiesi’s UK-based subsisdiary, was not disclosed. The seller was ventu... |
| Dec 6, 2011 | CRTX respiratory distress drug study draws $10M lawsuit from ONY | Amherst, New York-based ONY filed the suit last week in U.S. District Court in Buffalo, the Buffalo News first reported. Cornerstone, based in Cary, North Carolina, has not yet filed an answer to the complaint and is not commenting on the s... |
| CRTX respiratory distress drug study draws $10M lawsuit from ONY | Cornerstone Therapeutics (NASDAQ:CRTX) is in the crosshairs of competitor ONY over a published study that concludes its respiratory drug is riskier to infants than Cornerstone’s. Privately held ONY claims damages of $10 million and is now s... |
Reviews 0
FAQ about The Chiesi Group
What has the press written about The Chiesi Group?
Parsers VC has collected 7 articles mentioning The Chiesi Group, among them “Chiesi Farmaceutici Buys Atopix Therapeutics, for €75M” (Nov 25, 2016) and “Chiesi Group acquires Atopix” (Nov 21, 2016).
Is The Chiesi Group still active?
Yes, The Chiesi Group is active; its latest activity on Parsers VC dates from Dec 17, 2025.